Arrow - Losartan potassium & Hydrochlorothiazide New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - losartan potassium & hydrochlorothiazide

teva pharma (new zealand) limited - hydrochlorothiazide 12.5mg; losartan potassium 50mg;   - film coated tablet - 50mg/12.5mg - active: hydrochlorothiazide 12.5mg losartan potassium 50mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc purified water   quinoline yellow starch titanium dioxide - for the treatment of hypertension, for patients in whom combination therapy is appropriate

CANDESARTAN/HCT SANDOZ 32/12.5mg candesartan cilexetil/hydrochlorothiazide 32mg/12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan/hct sandoz 32/12.5mg candesartan cilexetil/hydrochlorothiazide 32mg/12.5mg tablet blister pack

sandoz pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: iron oxide yellow; lactose monohydrate; povidone; carrageenan; magnesium stearate; croscarmellose sodium; iron oxide red; iron oxide black; maize starch - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

CANDESARTAN/HCT SANDOZ 16mg/12.5mg candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan/hct sandoz 16mg/12.5mg candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack

sandoz pty ltd - candesartan cilexetil, quantity: 16 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: magnesium stearate; carrageenan; lactose monohydrate; maize starch; iron oxide red; croscarmellose sodium; povidone; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

CANDESARTAN/HCT SANDOZ 16mg/12.5mg candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan/hct sandoz 16mg/12.5mg candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet bottle

sandoz pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet - excipient ingredients: iron oxide yellow; povidone; iron oxide red; magnesium stearate; carrageenan; croscarmellose sodium; maize starch; lactose monohydrate - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Exforge HCT 10/160/12.5 12.5 mg, 160 mg, 10 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

exforge hct 10/160/12.5 12.5 mg, 160 mg, 10 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - hydrochlorothiazide 12.5 mg, valsartan 160 mg, amlodipine 10 mg - 12.5 mg, 160 mg, 10 mg

STADA IRBESARTAN HCT 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; povidone; microcrystalline cellulose; magnesium stearate; hydrogenated castor oil; maize starch; lactose monohydrate - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

STADA IRBESARTAN HCT 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; povidone; hydrogenated castor oil; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

ARW OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil/hydrochlorothiazide 40/12.5 mg film coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

arw olmesartan hctz 40/12.5 olmesartan medoxomil/hydrochlorothiazide 40/12.5 mg film coated tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; hyprolose; purified water; microcrystalline cellulose; hypromellose; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

Olmesartan/HCT Sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/hct sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack

sandoz pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; hypromellose; hyprolose; magnesium stearate; purified water; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil/hydrochlorothiazide 40/12.5 mg film coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-olmesartan hctz 40/12.5 olmesartan medoxomil/hydrochlorothiazide 40/12.5 mg film coated tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified water; hyprolose; lactose monohydrate; microcrystalline cellulose; hypromellose; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.